19. Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

Summary of consolidated stock-based compensation expense, by type of awards

The following table summarizes the consolidated share-based compensation expense from continuing operations, by type of awards: 

	For the Years Ended
	December 31,		December 31,		December 31,
	2020		2019		2018
Employee stock options	$	315	$	305	$	1,799
Restricted stock grants		–		516		927
Total share-based compensation expense	$	315	$	821	$	2,726

Summary of consolidated stock-based compensation by line items

The following table summarizes the consolidated share-based compensation by line items from continuing operations:

	For the Years Ended
	December 31, 2020		December 31, 2019		December 31, 2018
General and administrative	$	296	$	768	$	2,579
Sales, marketing and customer service		19		53		147
Total share-based compensation expense	$	315	$	821	$	2,726
Total share-based compensation expense after income taxes	$	315	$	821	$	2,726

Summary of assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants

Assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants were as follows:

	For the Years Ended
	December 31, 2020		December 31, 2019		December 31, 2018
Expected term		6.25		6.25		6.25
Risk-free interest rate		0.07%-0.09%		1.55%-2.51%		2.54%-3.03%
Expected volatility		537%-762%		575%-605%		624%-756%
Expected dividend yield		0%		0%		0%

Summary of stock option activities

	Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of December 31, 2017		501,260			66		7.03	$	769
Granted		287,000			13
Exercised		–			–
Forfeited/expired		(528,060	)		10
Outstanding as of December 31, 2018		260,200			212		8.59	$	–
Granted		65,000			3
Exercised		–			–
Forfeited/expired		(70,000	)		4		22.05
Outstanding as of December 31, 2019		255,200			19		6.70	$	–
Granted		300,000			9		10.00
Exercised		(109,500	)		4
Forfeited/expired		(56,800	)		27		6.00
Outstanding as of December 31, 2020		388,900			11		7.52	$	486
Vested and exercisable as of December 31, 2020		37,450			36		5.35	$	49
Expected to vest as of December 31, 2020		215,229			13		7.44	$	349

Summary of exercise price and remaining life information about options exercisable

Range of exercise price	Shares Exercisable		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Aggregate Intrinsic ($000)
$118 - $172		1,000		4.12		172.00		–
$40 - $117		14,600		5.38		62.03		–
$3 - $39		18,100		5.92		15.03		28
$1-$2		3,750		9.25		2.24		21
		37,450						49

Summary of restricted stock awards

Following is a summary of our restricted stock awards as follows:

	Number of Shares			Weighted Average Grant-Date Fair Value
Restricted stock units at December 31, 2017		215,809		$	151
Granted		663,460		$	1
Forfeited		(250	)	$	185
Restricted stock units at December 31, 2018		879,019		$	38
Granted		107,000		$	3
Forfeited		–		$	–
Restricted stock units at December 31, 2019		986,019		$	34
Granted		–		$	–
Forfeited		–		$	–
Restricted stock units at December 31, 2020		986,019		$	34

Summary of changes in non-vested stock awards

Changes in the Group’s non-vested stock awards are summarized as follows:

	Time-based Options					Restricted Stock
	Shares			Weighted Average Exercise Price Per Share		Shares			Weighted Average Grant-Date Fair Value Per Share
Non-vested as of December 31, 2017		379,920		$	9		1,313		$	264
Granted		287,000			13		663,460			1
Vested		(87,285	)		25		(663,273	)		1
Forfeited		(396,335	)		13		(250	)		185
Non-vested as of December 31, 2018		183,300		$	8		1,250		$	185
Granted		65,000			3		107,000			3
Vested		(70,050	)		17		(108,250	)		5
Forfeited		(62,500	)		4		–			–
Non-vested as of December 31, 2019		115,750		$	11		–		$	–
Granted		300,000			9		–			–
Vested		(50,350	)		9		–			–
Forfeited		(13,950	)		50		–			–
Non-vested as of December 31, 2020		351,450		$	8		–		$	–